TAP tapped by Shire for Lialda co-promote
Shire has entered a three-year deal with TAP Pharmaceutical to co-promote ulcerative colitis treatment, Shire's Lialda, in the US.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.